Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 1, 2010
Sertoli-Leydig cell tumour in a 13-year-old girlBettina Böttcher, Bernd Hinney, Johanna Keyser, et al.Diagnostic Pathology|February 15, 2013
Sertoliform cystadenoma: a rare benign tumour of the rete testisFelix Bremmer, Stefan Schweyer, Carl Ludwig Behnes, et al.BMC Cancer|September 26, 2012
Blastomatoid pulmonary carcinosarcoma: report of a case with a review of the literatureInga-Marie Schaefer, Carsten-Oliver Sahlmann, Tobias Overbeck, et al.Oncology Reports|February 19, 2011
Targeted chemotherapy for triple-negative breast cancers via LHRH receptorCrispin Föst, Francesca Duwe, Martin Hellriegel, et al.Immunobiology|March 6, 2007
Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneysZiba Kiafard, Thomas Tschernig, Stefan Schweyer, et al.International Journal of Oncology|December 5, 2003
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cellsPaul Thelen, Stefan Schweyer, Bernhard Hemmerlein, et al.Journal of Medical Virology|May 29, 2009
TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis CEva Askar, Rusudan Bregadze, Jasmin Mertens, et al.The American Journal of Pathology|July 24, 2003
Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cellsMichal Grzmil, Paul Thelen, Bernhard Hemmerlein, et al.Anticancer Research|March 2, 2005
Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamideThilo Schlott, Helge Taubert, Afshin Fayyazi, et al.Molecular Cancer Therapeutics|October 5, 2007
The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatmentMark Stettner, Silke Kaulfuss, Peter Burfeind, et al.Pageof 4